Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

Published:2021-06 Issue:7 Volume:5 Page:740-749
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Davison Beth A¹²^ORCID,Edwards Christopher¹,Loomba Rohit³,Harrison Stephen A⁴,Cotter Gad¹²,Alkhouri Naim⁵,Koch Gary G⁶,Dittrich Howard C⁷

Affiliation:

1. Momentum Research, Inc. North Carolina USA

2. Inserm U942 Cardiovascular Markers in Stressed Conditions (MASCOT) Paris France

3. NAFLD Research Center Division of Gastroenterology University of California at San Diego La Jolla California USA

4. Hepatology, Radcliffe Department of Medicine University of Oxford Oxford UK

5. Metabolic Health Center Texas Liver Institute San Antonio Texas USA

6. Department of Biostatistics, School of Public Health University of North Carolina Chapel Hill North Carolina USA

7. Chief Medical Officer Cirius Therapeutics, Inc. San Diego California USA

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12575

Reference35 articles.

1. The global NAFLD epidemic

2. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health

3. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

4. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study;Clinical Gastroenterology and Hepatology;2024-01

2. Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study;Chinese Medical Journal;2023-02-05

3. Precision medicine in nonalcoholic fatty liver disease;Journal of Gastroenterology and Hepatology;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3